BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 16779701)

  • 1. Nanotechnology: intelligent design to treat complex disease.
    Couvreur P; Vauthier C
    Pharm Res; 2006 Jul; 23(7):1417-50. PubMed ID: 16779701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer nanotechnology: small, but heading for the big time.
    Nat Rev Drug Discov; 2007 Mar; 6(3):174-5. PubMed ID: 17396287
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in technology and business potential of new drug delivery systems.
    Momin M; Disouza J; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):341. PubMed ID: 27365167
    [No Abstract]   [Full Text] [Related]  

  • 4. Advanced drug delivery in motion.
    Mastrobattista E
    Int J Pharm; 2013 Sep; 454(1):517-20. PubMed ID: 23665006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues and concerns in nanotech product development and its commercialization.
    Kaur IP; Kakkar V; Deol PK; Yadav M; Singh M; Sharma I
    J Control Release; 2014 Nov; 193():51-62. PubMed ID: 24933600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9th International drug delivery technologies & deal-making summit.
    Panzner S; Smith PL
    Expert Opin Drug Deliv; 2005 Jan; 2(1):189-90. PubMed ID: 16296745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dangers of generalization in nanotechnology.
    Florence AT
    Drug Discov Today; 2004 Jan; 9(2):60-1. PubMed ID: 15025067
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.
    Smola M; Vandamme T; Sokolowski A
    Int J Nanomedicine; 2008; 3(1):1-19. PubMed ID: 18488412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotech approaches to drug delivery and imaging.
    Sahoo SK; Labhasetwar V
    Drug Discov Today; 2003 Dec; 8(24):1112-20. PubMed ID: 14678737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connecting drug delivery reality to smart materials design.
    Grainger DW
    Int J Pharm; 2013 Sep; 454(1):521-4. PubMed ID: 23624177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart drug delivery systems: back to the future vs. clinical reality.
    Lammers T
    Int J Pharm; 2013 Sep; 454(1):527-9. PubMed ID: 23485339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will nanomedicine deliver on its promise of changing therapeutics or remain an interesting and important research tool in cell biology and physiology?
    Kirsh R; Hood S; Brook C; Gilmartin A; Dell'orco P; Meek T
    Int J Pharm; 2013 Sep; 454(1):530-1. PubMed ID: 23816474
    [No Abstract]   [Full Text] [Related]  

  • 13. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
    Brown D
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active drug targeting: lessons learned and new things to consider.
    Al-Jamal KT
    Int J Pharm; 2013 Sep; 454(1):525-6. PubMed ID: 23558315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery in biotechnology: present and future.
    Orive G; Hernández RM; Rodríguez Gascón A; Domínguez-Gil A; Pedraz JL
    Curr Opin Biotechnol; 2003 Dec; 14(6):659-64. PubMed ID: 14662398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
    Stegemann S
    Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobiotech in big pharma: a business perspective.
    Würmseher M; Firmin L
    Nanomedicine (Lond); 2017 Mar; 12(5):535-543. PubMed ID: 28178881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in recognitive, conductive and responsive delivery systems.
    Bayer CL; Peppas NA
    J Control Release; 2008 Dec; 132(3):216-21. PubMed ID: 18652857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.